[Tocilizumab for refractory systemic juvenile idiopathic arthritis]. [electronic resource]
- Zhonghua er ke za zhi = Chinese journal of pediatrics Nov 2017
- 830-834 p. digital
Publication Type: Journal Article
0578-1310
10.3760/cma.j.issn.0578-1310.2017.11.008 doi
Antibodies, Monoclonal, Humanized--adverse effects Arthritis, Juvenile--drug therapy Blood Sedimentation C-Reactive Protein Case-Control Studies Child Child, Preschool Drug-Related Side Effects and Adverse Reactions Female Fever Humans Interleukin-6 Male Prospective Studies Treatment Outcome Tumor Necrosis Factor-alpha